Merck KGaA Flags 2026 Earnings Drop as Mavenclad Faces Generics
Merck KGaA forecast a sluggish year ahead, with the possibility of falling profits, as generic competition for its multiple sclerosis…
Tag: generics
Rare Disease Momentum and Generics Expansion Drive Upgraded Outlook
Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) reported Q3 CY2025 results topping the market’s revenue expectations , with sales up 53.6%…
CapVest to buy control of generics giant Stada in €10bn deal
CapVest Partners has agreed to purchase a majority stake in German generics manufacturer Stada Arzneimittel, marking one of the largest…